Author

Sarah Chatley

Roswell Park Comprehensive Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Andrei V. BakiniD· 1 shared Barbara A. FosteriD· 1 shared Christos K FountzilasiD· 1 shared Henry G. WithersiD· 1 shared Justin ZonnevilleiD· 1 shared Mohammed AlruwailiiD· 1 shared Priyanka RajaniD· 1 shared Renuka V. IyeriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrei V. BakinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant Cancers

Mohammed Alruwaili, Yanqi Guo, Justin Zonneville, Thomas Melendy, Robert M. Straubinger, Barbara A. Foster, Priyanka Rajan, Henry G. Withers, Sarah Chatley, Renuka V. Iyer, Christos K Fountzilas, Andrei V. Bakin

This paper develops a sequential triple-drug strategy targeting p53 mutant cancers, showing it effectively induces cell death while minimizing toxicity to normal cells.

bioRxiv · Nov 6, 2025 · PreprintCancer Biology